Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alvogyl vs Platelet-Rich Fibrin for Alveolar Osteitis
NCT07790653Completed
- Sponsor
- CMH Lahore Medical College and Institute of Dentistry
- Start
- Feb 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of platelet-rich fibrin cream (Poznan University of Medical Sciences) in alveolar osteitis (AO) (2 arms), sponsored by CMH Lahore Medical College and Institute of Dentistry. Primary endpoints: Mean Pain Score at Day 3 and Mean Number of Socket Wall Exposures at Day 3. Started Feb 2026; status: completed.
02
Drugs
platelet-rich fibrin cream (Poznan University of Medical Sciences)
03
Conditions
alveolar osteitis (AO)
Beyond the preview
Go deeper on NCT07790653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790653.